Abstract
Mutations in Btk result in the B cell immunodeficiencies X-linked agammaglobulinemia (XLA) in humans and X-linked immunodeficiency (xid) in mice. Btk is a critical component of signaling pathways regulating B cell development and function. We used a genetic approach to determine whether Btk is also limiting for these processes. One allele of a murine Btk transgene expressed a dosage of Btk (25% of endogenous levels in splenic B cells) sufficient to restore normal numbers of phenotypically mature conventional B cells in xid mice. 2,4,6-trinitrophenyl–Ficoll response, anti-IgM-induced proliferation, B1 cell development, and serum IgM and IgG3levels remained significantly impaired in these animals. B cells from Btk −/− transgenic mice also responded poorly to anti-IgM, indicating that the xid mutation does not create a dominant negative form of Btk. Response to 2,4,6-trinitrophenyl–Ficoll and B cell receptor cross-linking were increased 3- to 4-fold in xid mice homozygous for the transgene. These results demonstrate that Btk is a limiting component of B cell antigen receptor signaling pathways and suggest that B cell development and response to antigen may require different levels of Btk activity.
References
63
Referenced
83
10.1073/pnas.93.6.2264
10.1126/science.1373518
10.1016/1074-7613(95)90157-4
-
F E Lund, N Yu, K-M Kim, M Reth, M C Howard J Immunol 157, 1455–1467 (1996).
(
10.4049/jimmunol.157.4.1455
) / J Immunol by Lund F E (1996) -
A Pezzutto, P S Rabinovitch, B Dorken, G Moldenhauer, E A Clark J Immunol 140, 1791–1795 (1988).
(
10.4049/jimmunol.140.6.1791
) / J Immunol by Pezzutto A (1988) 10.1126/science.7618087
10.1016/S0960-9822(06)00057-1
10.1126/science.274.5288.798
10.1038/384634a0
10.1016/S1074-7613(00)80270-8
10.1016/1074-7613(95)90075-6
10.1126/science.7716523
10.1084/jem.181.6.2077
10.1038/381325a0
10.1016/0092-8674(93)90667-F
10.1038/361226a0
10.1126/science.8332901
10.1126/science.8332900
-
D Campana, J Farrant, N Inamdar, A D B Webster, G Janossy J Immunol 145, 1675–1680 (1990).
(
10.4049/jimmunol.145.6.1675
) / J Immunol by Campana D (1990) 10.1542/peds.9.6.722
10.1093/nar/25.1.166
10.1016/1074-7613(95)90115-9
10.1016/1074-7613(95)90114-0
10.1002/j.1460-2075.1996.tb00867.x
10.1038/306270a0
10.1084/jem.147.3.814
10.1093/intimm/5.9.1183
10.1084/jem.172.6.1625
10.1093/intimm/7.2.163
10.1182/blood.V85.3.627.bloodjournal853627
10.1128/mcb.14.8.5108-5113.1994
10.1084/jem.149.4.993
10.1084/jem.142.3.637
10.1002/eji.1830160423
- E F Faust, D J Rawlings, D C Saffran, O N Witte Contemporary Topics in Microbiology and Immunology: Mechanisms in B-Cell Neoplasia, eds M Potter, F Melchers (Springer, Berlin) 1, 363–370 (1994). / Contemporary Topics in Microbiology and Immunology: Mechanisms in B-Cell Neoplasia by Faust E F (1994)
10.1073/pnas.94.2.610
10.1084/jem.177.2.305
10.1128/mcb.9.5.1866-1874.1989
10.1016/0092-8674(93)90111-3
10.1126/science.271.5250.822
10.1084/jem.151.1.224
- M J Bykowsky, R N Haire, Y Ohta, H Tang, S S Sung, E S Veksler, J M Greene, S M Fu, G W Litman, K E Sullivan Am J Hum Genet 58, 477–483 (1996). / Am J Hum Genet by Bykowsky M J (1996)
-
R T Woodland, M R Schmidt, S J Korsmeyer, K A Gravel J Immunol 156, 2143–2154 (1996).
(
10.4049/jimmunol.156.6.2143
) / J Immunol by Woodland R T (1996) 10.1016/S1074-7613(00)80418-5
10.1126/science.273.5276.788
10.1084/jem.185.6.981
10.1073/pnas.81.8.2494
10.1002/eji.1830170414
10.1084/jem.175.5.1213
10.1084/jem.152.5.1194
10.1016/0008-8749(82)90325-2
10.1128/MCB.16.7.3465
10.1128/MCB.15.10.5304
10.1073/pnas.91.23.11256
10.1016/S0021-9258(17)34048-6
10.1073/pnas.92.19.8601
10.1073/pnas.91.19.9175
10.1084/jem.150.1.31
10.1172/JCI110651
-
C L Scribner, C T Hansen, D M Klinman, A D Steinberg J Immunol 138, 3611–3617 (1987).
(
10.4049/jimmunol.138.11.3611
) / J Immunol by Scribner C L (1987) 10.1016/S1074-7613(00)80511-7
10.1084/jem.184.3.831
10.1084/jem.177.3.857
Dates
Type | When |
---|---|
Created | 23 years, 1 month ago (July 26, 2002, 10:32 a.m.) |
Deposited | 2 years, 4 months ago (April 22, 2023, 8:11 a.m.) |
Indexed | 1 week, 1 day ago (Aug. 24, 2025, 6:50 p.m.) |
Issued | 27 years, 9 months ago (Nov. 25, 1997) |
Published | 27 years, 9 months ago (Nov. 25, 1997) |
Published Online | 27 years, 9 months ago (Nov. 25, 1997) |
Published Print | 27 years, 9 months ago (Nov. 25, 1997) |
@article{Satterthwaite_1997, title={Btk dosage determines sensitivity to B cell antigen receptor cross-linking}, volume={94}, ISSN={1091-6490}, url={http://dx.doi.org/10.1073/pnas.94.24.13152}, DOI={10.1073/pnas.94.24.13152}, number={24}, journal={Proceedings of the National Academy of Sciences}, publisher={Proceedings of the National Academy of Sciences}, author={Satterthwaite, Anne B. and Cheroutre, Hilde and Khan, Wasif N. and Sideras, Pascalis and Witte, Owen N.}, year={1997}, month=nov, pages={13152–13157} }